09/29/2020 12:00 AM EDT
Source: U.S. Food and Drug Administration (FDA). Published: 9/29/2020. This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the FREND COVID-19 total Ab. The FREND COVID-19 total Ab is authorized for the qualitative detection of total antibodies to SARS-CoV-2 in human dipotassium EDTA plasma. (PDF)
No hay comentarios:
Publicar un comentario